Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Clinical Trials in Portland | 9,742 Studies Near You

Clinical TrialsPortland

Clinical Trials in Portland

Discover 9,742 clinical trials near Portland, Oregon. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 9,742 trials

CompletedS0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast CancerRATIONALE: Cholecalciferol may prevent breast cancer in premenopausal women.NCT01097278·Anniston, Alabama and 359 others

Find Trials by Condition in Portland

Breast Cancerin Portland Lung Cancerin Portland Prostate Cancerin Portland Colorectal Cancerin Portland Melanomain Portland Leukemiain Portland Lymphomain Portland Pancreatic Cancerin Portland Ovarian Cancerin Portland Brain Cancerin Portland Diabetes

Data from ClinicalTrials.govTerms

CompletedHybrid Immunotherapy for Hemophagocytic LymphoHistiocytosisDespite good progress during the last decade, hemophagocytic lymphohistiocytosis (HLH) remains difficult to treat. Two different treatment regimens have been used successfully.NCT01104025·Phoenix, Arizona and 14 others

CompletedSafety and Efficacy of Coformulated Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib (E7080/MK-7902) in Advanced Hepatocellular Carcinoma (MK-1308A-004)The purpose of this study is to evaluate the safety and efficacy of fixed dose coformulated pembrolizumab/quavonlimab (MK-1308A) plus lenvatinib in a first line (1L)…NCT04740307·Duarte, California and 39 others

Active not recruitingA Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study of Two Doses of VP-001 Administered Intravitreally in Participants With Confirmed PRPF31 Mutation-Associated Retinal Dystrophy, Including Participants Previously Treated With VP001This is a Phase 1/2 repeat-dose, open-label, two-arm, parallel group safety and efficacy study of two doses of VP-001 (30 μg and 75 μg) in participants with confirmed PRPF31…NCT06852963·Jacksonville, Florida and 5 others

TerminatedClopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)The purpose of the COGENT-1 clinical trial is to determine whether CGT-2168 (clopidogrel and omeprazole) compared to clopidogrel is safe and effective in reducing the incidence of…NCT00557921·Alexander City, Alabama and 490 others

CompletedStudy Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing SpondylitisThis was a study estimating the clinical difference between 300 mg and 150 mg of secukinumab following dose escalation to 300 mg in patients with ankylosing spondylitisNCT03350815·Jonesboro, Arkansas and 64 others

CompletedOpen-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 TrialThe purpose of this study is to evaluate the safety, tolerability and activity of Fampridine-SR when administered for up to 36 additional months, or until it becomes commercially…NCT00648908·Phoenix, Arizona and 31 others

RecruitingTargeted Pathway Inhibition in Patients With Pancreatic CancerThis early phase I trial aims to determine how cobimetinib, olaparib, onvansertib, azenosertib, AZD5305 or tremelimumab works in patients with pancreatic cancer.NCT04005690·Portland, Oregon

CompletedA Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM)This feasibility study will assess the effects of the Nativis Voyager therapy in patients with first or second recurrence of GBM who have either failed standard of care or are…NCT02296580·Birmingham, Alabama and 12 others

CompletedLung-MAP: Durvalumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching BiomarkersThis phase II trial studies how well durvalumab works in treating patients with stage IV squamous cell lung cancer that has come back after previous treatment.NCT02766335·Birmingham, Alabama and 992 others

Active not recruitingStudy of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS MutationThe purpose of this study is to assess 2 different doses of onvansertib to select the lowest dose that is maximally effective, and to assess the safety, efficacy…NCT06106308·Phoenix, Arizona and 40 others

Active not recruitingA Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.This is a parallel, Phase 3, two-arm study for the treatment of newly diagnosed moderate or severe chronic GVHD.NCT06143891·Little Rock, Arkansas and 150 others

RecruitingTrastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell TumorThis phase I/II trial studies the effects of trastuzumab deruxtecan (DS-8201a) in treating patients with osteosarcoma, Wilms tumor (WT) or desmoplastic small round cell tumor…NCT04616560·Birmingham, Alabama and 29 others

CompletedPerspectives on Prophylactic Antibiotic Use in Dermatologic SurgeryThis is a prospective, multi-center observational survey study to uncover how antibiotic differences can influence utilization decisions.NCT04150523·Davis, California and 7 others

CompletedA Study of Azenosertib (ZN-c3) in Women With Recurrent or Persistent Uterine Serous CarcinomaThis is a Phase 2 study to evaluate the clinical activity and safety of ZN-c3 (azenosertib) in adult women with recurrent or persistent uterine serous carcinoma (USC).NCT04814108·Anchorage, Alaska and 55 others

TerminatedStudy of Ruxolitinib in Colorectal Cancer PatientsThe purpose of this study was to determine if ruxolitinib, in combination with regorafenib, is safe and effective in the treatment of metastatic colorectal cancer.NCT02119676·Chandler, Arizona and 85 others

CompletedSuppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast CancerRATIONALE: Estrogen can stimulate the growth of breast tumor cells.NCT00066690·Birmingham, Alabama and 499 others

CompletedStudy of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary FibrosisStudy RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FVC) from baseline to Week 52.NCT04708782·Birmingham, Alabama and 97 others

UnknownA Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPCThis will be a blinded, placebo-controlled, randomized, phase 2 study in which subjects will be randomly assigned 1:1 to cemiplimab plus placebo or cemiplimab plus ISA101b.NCT03669718·Duarte, California and 43 others

CompletedCombination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell TumorsRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00002596·Anniston, Alabama and 152 others

PreviousPage 5 of 488Next

in Portland

Heart Diseasein Portland